BOS-589
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BOS-589, covering 2021-06-07 to 2021-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]